Live from the NIH registry
Studies recruiting near Fayetteville right now
Top 25 of 125 recruiting studies, sorted by proximity — each links to its official registry page
C-Brace Prospective Registry
Pareses, Lower Extremity
N/A
Observational 250 participants sought
O&P of Pinehurst — Pinehurst, North Carolina (28.8 mi)
· Sponsor: Otto Bock Healthcare Products GmbH
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
Non-Small Cell Lung Cancer (NSCLC)
Phase 3
Interventional 750 participants sought
FirstHealth Cancer Center — Pinehurst, North Carolina (28.8 mi)
· Sponsor: Amgen
Scheduled or As Needed Pain Regimen?
Pain, Postoperative
Phase 4
Interventional 90 participants sought
Cape Fear Valley Medical Center — Fayetteville, North Carolina (6.0 mi)
· Sponsor: Cape Fear Valley Health System
Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
Endometrial Cancer
Phase 3
Interventional 710 participants sought
FirstHealth of the Carolinas, Inc. — Pinehurst, North Carolina (28.8 mi)
· Sponsor: Daiichi Sankyo
CBT-I vs. MBTI for Traumatic Brain Injury (TBI)-Related Insomnia and Post-Traumatic Stress Symptoms
Traumatic Brain Injury, Insomnia
N/A
Interventional 360 participants sought
Womack Army Medical Center — Fort Bragg, North Carolina (4.1 mi)
· Sponsor: Johns Hopkins University
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Triple-Negative Breast Cancer
Phase 3
Interventional 1,530 participants sought
Cape Fear Valley Health System ( Site 0136) — Fayetteville, North Carolina (6.0 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Non-Small Cell Lung Cancer, KRAS G12C Lung Cancer
Phase 3
Interventional 600 participants sought
Firsthealth of The Carolinas — Pinehurst, North Carolina (28.8 mi)
· Sponsor: Hoffmann-La Roche
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Advanced Non-Small Cell Lung Cancer, Non-Small Cell Lung Cancer
Phase 3
Interventional 1,410 participants sought
FirstHealth Cancer Center — Pinehurst, North Carolina (28.8 mi)
· Sponsor: Pfizer
Comparative Performance of a Vaginal Yeast Test
Vulvovaginal Candidiasis
N/A
Observational 1,200 participants sought
Womack Army Medical Center — Fort Bragg, North Carolina (4.1 mi)
· Sponsor: Uniformed Services University of the Health Sciences
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
Phase 3
Interventional 1,350 participants sought
89bio Clinical Study Site — Fayetteville, North Carolina (6.0 mi)
· Sponsor: 89bio, Inc.
Safety and Efficacy of Boric Acid Inserts for Treatment of Vulvovaginal Candidiasis
Vulvovaginal Candidiases, Vulvovaginal Candidiasis, Genital
Phase 3
Interventional 400 participants sought
Cross Creek Medical Clinic, PA — Fayetteville, North Carolina (6.0 mi)
· Sponsor: pH-D Feminine Health LLC
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
Metabolic Dysfunction Associated Steatohepatitis
Phase 3
Interventional 1,590 participants sought
Coastal Research Institute, LLC — Fayetteville, North Carolina (6.0 mi)
· Sponsor: Boehringer Ingelheim
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Ulcerative Colitis, Obesity or Overweight
Phase 3
Interventional 350 participants sought
Coastal Research Institute - Fayetteville — Fayetteville, North Carolina (6.0 mi)
· Sponsor: Eli Lilly and Company
Integrated Cancer Repository for Cancer Research
Multiple conditions
N/A
Observational 999,999 participants sought
Cape Fear Valley Health System — Fayetteville, North Carolina (6.0 mi)
· Sponsor: University of Nebraska
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
Heart Failure and Impaired Kidney Function
Phase 3
Interventional 4,800 participants sought
Research Site — Pinehurst, North Carolina (28.8 mi)
· Sponsor: AstraZeneca
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Heart Failure
Phase 3
Interventional 4,200 participants sought
Pinehurst Medical Clinic, Inc. - East — Pinehurst, North Carolina (28.8 mi)
· Sponsor: Boehringer Ingelheim
Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients
Non Small Cell Lung Cancer, Epidermal Growth Factor Receptor Gene Mutation
N/A
Observational 538 participants sought
FirstHealth of the Carolinas-Moore Regional Hospital — Pinehurst, North Carolina (28.8 mi)
· Sponsor: PrECOG, LLC.
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
Castration-Sensitive Prostate Carcinoma, Metastatic Prostate Adenocarcinoma
Phase 3
Interventional 1,260 participants sought
FirstHealth of the Carolinas-Moore Regional Hospital — Pinehurst, North Carolina (28.8 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Ulcerative Colitis
Phase 3
Interventional 980 participants sought
Cross Creek Medical Clinic - Site Number: 8400057 — Fayetteville, North Carolina (6.0 mi)
· Sponsor: Sanofi
Pre- and Post-neuromusculoskeletal Injury Risk Evaluation for Return-to-Duty Enhancement
Musculoskeletal Injuries
N/A
Observational 2,690 participants sought
Womack Army Medical Center — Fort Liberty, North Carolina (4.0 mi)
· Sponsor: Womack Army Medical Center
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Ulcerative Colitis
Phase 3
Interventional 751 participants sought
Cross Creek Medical Clinic - Site Number: 8400057 — Fayetteville, North Carolina (6.0 mi)
· Sponsor: Sanofi
Examining the Efficacy of Short-Term Intensive PTSD Treatment on Psychological and Cognitive Impairment Symptoms
PTSD, Cognitive Performance
N/A
Interventional 120 participants sought
Fort Bragg — Fayetteville, North Carolina (6.0 mi)
· Sponsor: Ohio State University
Confirmatory Clinical Study in Active Ulcerative Colitis
Colitis, Ulcerative
Phase 2
Interventional 204 participants sought
Cross Creek Medical Clinic — Fayetteville, North Carolina (6.0 mi)
· Sponsor: MRM Health NV
Product Surveillance Registry
Cardiac Rhythm Disorders, Urological Disorders
N/A
Observational 100,000 participants sought
Research site — Pinehurst, North Carolina (28.8 mi)
· Sponsor: Medtronic
A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma
Endometrial Adenocarcinoma
Phase 2
Interventional 350 participants sought
FirstHealth of the Carolinas — Pinehurst, North Carolina (28.8 mi)
· Sponsor: Acrivon Therapeutics